A shocking blow to baseball fans everywhere: Veteran outfielder Max Kepler has been suspended for 80 games after testing positive for the performance-enhancing drug Epitrenbolone, Major League Baseball announced on Friday. But here's where it gets controversial – is this a case of intentional cheating, or a costly mistake? Let's dive in.
Kepler, a 32-year-old free agent, spent last season with the Philadelphia Phillies, playing 127 games and hitting 18 home runs. However, his performance was a far cry from his peak years with the Minnesota Twins, where he spent a decade after his 2015 debut. As a left-handed corner outfielder, Kepler has amassed a career slash line of .235/.316/.425 with 179 home runs, much of which came against right-handed pitching. And this is the part most people miss – despite his struggles last season, Kepler's career numbers still paint the picture of a solid contributor.
Last season with the Phillies, Kepler's numbers took a nosedive, as he hit just .216/.300/.391 with 18 home runs. His OPS+ of 88 was the lowest of his career, raising questions about his future in the league. Now, with this suspension, Kepler's career is at a crossroads. Is this the end of the line for the veteran outfielder, or will he bounce back stronger than ever?
The use of performance-enhancing drugs in sports is a contentious issue, with some arguing that it's a necessary evil to stay competitive, while others see it as a blatant violation of the rules. What do you think – is Kepler's suspension justified, or is the punishment too harsh? Let's spark a debate in the comments.
As we ponder Kepler's future, it's worth noting that his case is not an isolated incident. The pressure to perform at the highest level can lead athletes to make questionable decisions, and the consequences can be devastating. But where do we draw the line between personal responsibility and systemic issues in sports? Weigh in with your thoughts below, and let's explore this complex topic together. Don't forget to follow Marc Carig, senior managing editor for The Athletic's MLB desk, on Twitter @MarcCarig for more insights and analysis on this developing story and other MLB news.
